Australia-based venture studio and innovation group BlueChilli today announced its partnership with Enterprise Singapore to launch a Singapore-based healthtech accelerator.
The BlueChilli HealthTech Accelerator aims to build and develop startups that address health challenges and opportunities in Southeast Asia.
“All startups who enter BlueChilli’s boot camp will receive free training and support through our online academy, startupu.io – so we want as many participants as possible! From there, BlueChilli will be selecting up to 15 startups to receive tech development through our accelerator this year,” a BlueChili spokesperson wrote in an email to e27.
Selected founders will get access to tech development services at no cost, startup training, seed funding, and a global network of advisors and mentors.
“We’re looking for people who are passionate about solving problems in the health sector using technology. No startup or tech experience is required for those who are interested in the program. BlueChilli will provide a world class team of experts to selected founders to build their products, gain market traction, secure investment and establish their first team,” the spokesperson further explained.
With the support from Enterprise Singapore, BlueChilli has also included CSIRO and Galen Growth Asia as health and innovation partners for the programme.
They are also set to announce more partners that include local healthcare providers.
“Our mission is to help people anywhere solve society’s greatest challenges with technology, so we are excited to extend our reach further into Southeast Asia,” said BlueChilli Founder and CEO Sebastien Eckersley-Maslin in a press statement.
“By removing the barriers of access to technology and capital, we can help a more diverse range of entrepreneurs in Southeast Asia bring their unique experiences and novel ideas to the global innovation ecosystem,” he continued.
Founded in 2011, BlueChilli has launched 132 startups that have collectively raised over US$170 million.
Its portfolio companies are operating in the Americas, Europe, Australia, and Southeast Asia.
The company first expanded to Singapore in early 2018, through a partnership with Hatcher+ to co-invest in 240 global tech startups.
In Indonesia, BlueChilli has also launched an innovation centre in partnership with Coca-Cola Amatil last month.
BlueChilli’s portfolio companies in the healthtech sector are hardware startups BindiMaps and Talkiplay, mammography AI diagnostics service Alixir.ai, telemedicine platform VetChat and out-of-home patient care platform CTARS.
The Asia Pacific healthtech sector itself is the second largest in the world for investment funds raised, according to a press statement by the company.
Last year, US$6.3 billion was deployed into healthtech startups in the region and this investment significantly exceeded the 2017 number and doubled the 2016 number.
The Southeast Asian healthtech ecosystem is still emerging within the region and is said to be poised for growth, with Singapore and Indonesia contributing to “most of its notable deals” in 2018.
Image Credit: BlueChilli